Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.250
-0.040 (-3.10%)
At close: Oct 29, 2025, 4:00 PM EDT
1.260
+0.010 (0.80%)
After-hours: Oct 29, 2025, 4:25 PM EDT
Canopy Growth Revenue
Canopy Growth had revenue of 72.13M CAD in the quarter ending June 30, 2025, with 8.94% growth. This brings the company's revenue in the last twelve months to 274.92M, down -4.24% year-over-year. In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M, down -9.47%.
Revenue (ttm)
274.92M CAD
Revenue Growth
-4.24%
P/S Ratio
2.00
Revenue / Employee
286,372 CAD
Employees
960
Market Cap
402.87M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
CGC News
- 5 days ago - Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025 - Business Wire
- 6 days ago - Canadian Cannabis Leaders Poised for Growth as U.S. Legalization Momentum Builds - MarijuanaStocks
- 15 days ago - Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders - Business Wire
- 18 days ago - Top 3 Canadian Cannabis Stocks to Watch in October 2025 - MarijuanaStocks
- 21 days ago - Canopy Growth Announces DOJA as Dedicated Canadian Medical Facility - Business Wire
- 22 days ago - JP Brand Advisors and Canopy USA Form Strategic Partnership to Expand Hemp Beverage Distribution - PRNewsWire
- 4 weeks ago - Best Canadian Cannabis Stocks to Watch for Growth and Opportunity - MarijuanaStocks
- 4 weeks ago - Wall Street Breakfast Podcast: Weed Stocks Light Up - Seeking Alpha